# The Longevity Shelf FAQ > Longevity & Cellular Health Research Peptides FAQ — Wellness Peptide Store — Direct answers about NAD+, Epitalon, longevity claims, evidence limits, safety, dosage questions, and cycling claims. **QUESTIONS / STRAIGHT ANSWERS** Eight common questions, answered from the composed literature without a protocol, pitch, or promise. ## What is NAD supplement used for? NAD+ products and the precursors NMN and NR are marketed around cellular energy, healthy aging, and metabolic function. The research record is narrower. NAD+ is a coenzyme involved in energy transfer and enzyme signaling [4]. Human trials show that NMN or NR can raise NAD+ in blood, and some studies report changes in walking performance, quality-of-life measures, or muscle insulin sensitivity [2][3][5]. Those outcomes do not prove age reversal, disease prevention, or longer life. Also, oral NAD+, oral precursors, and compounded infusions are different interventions; evidence for one should not be pasted onto another. ## What is the downside of taking NAD+? The first downside is uncertainty: blood NAD+ can rise without proving a meaningful clinical benefit [1]. Product format and quality also matter. Oral NAD+ has a different absorption rationale from NMN or NR, while compounded injectable products add manufacturing and contamination risks. Short precursor trials cannot establish long-term safety. The role of NAD+ in cancer biology is context-dependent because proliferating cells also use cellular energy and repair pathways. This site cannot determine personal risk or suitability; it reports why the broad wellness claim outruns the evidence. ## Is it safe to take NAD daily? The available corpus does not support a universal yes-or-no answer or a daily-use recommendation. Some controlled precursor studies reported no meaningful adverse-event difference from placebo during their study periods [2][5]. That is evidence about defined products, participants, and limited durations—not every NAD+-labeled product, route, health condition, or long-term exposure. Compounded injectable NAD+ is not equivalent to an oral precursor and carries additional quality-control concerns. A literature digest cannot turn short trial tolerability into individual medical guidance. ## Does NAD cause weight gain? The cited research does not establish NAD+ or its precursors as a cause of weight gain. In one NMN trial focused on muscle insulin sensitivity, body composition did not change [3]. That specific result should not be exaggerated in either direction: it does not show weight gain, and it does not establish a weight-loss effect. Body weight can change for many reasons, while NAD+ studies differ in formulation, population, and endpoint. The evidence here supports a narrow answer rather than a promise. ## What is Epitalon? Epitalon is a synthetic peptide made from four amino acids, commonly represented as AEDG. It is derived from the composition of Epithalamin, a bovine pineal extract, but the two are not identical. Laboratory research links Epitalon with telomerase activity, telomere length, and melatonin-related signaling [9][10][11]. A recent review describes several proposed geroprotective mechanisms while noting limited structural characterization and unresolved mechanism questions [8]. It has no approved human indication in major Western markets. ## What are the benefits of Epitalon according to research? The safest wording is **observed effects in experimental models**, not proven benefits. Human-cell studies report telomerase activation and telomere elongation [9][11]. Rat pineal-cell research reports increased activity in a melatonin-synthesis pathway [10]. An observational study of the related extract Epithalamin reported an association with reduced mortality, but it was not randomized or placebo-controlled and does not establish a causal effect of synthetic Epitalon [12]. Reports of improved sleep or vitality in longevity communities are anecdotal, not clinical evidence. ## What is the recommended dosage of Epitalon in research protocols? This site does not provide or recommend a human dose. Epitalon is unapproved for human use in major Western markets, lacks a settled human pharmacokinetic profile, and does not have a robust body of randomized human trials from which a responsible regimen could be derived [8]. Laboratory concentrations and historical experimental schedules answer questions about how a specific study was run; they are not instructions for self-administration. Turning them into a protocol would cross the line from evidence summary to unsafe medical advice. ## How often should Epitalon be cycled, once or twice a year? There is no evidence-based cycling schedule established by the corpus, so this digest does not endorse annual, twice-yearly, or any other use. The question assumes that repeated human use is effective and acceptably safe; those points have not been demonstrated. The core evidence remains largely mechanistic, cell-based, or observational [8][9][10][11][12]. Community cycle reports are anecdotal, not clinical evidence, and uncertain product identity adds another uncontrolled variable. A repeated-use schedule cannot be reverse-engineered responsibly from that record. --- An independent audit of the longevity shelf—cellular mechanisms and human findings, not a checkout, prescription, or promise of extra years.